Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis
Barbara Rivera, … , Marc R. Fabian, William D. Foulkes
Barbara Rivera, … , Marc R. Fabian, William D. Foulkes
Published December 5, 2019
Citation Information: J Clin Invest. 2020;130(3):1479-1490. https://doi.org/10.1172/JCI130206.
View: Text | PDF
Clinical Research and Public Health Genetics Oncology Article has an altmetric score of 4

DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis

  • Text
  • PDF
Abstract

BACKGROUND DICER1 is the only miRNA biogenesis component associated with an inherited tumor syndrome, featuring multinodular goiter (MNG) and rare pediatric-onset lesions. Other susceptibility genes for familial forms of MNG likely exist.METHODS Whole-exome sequencing of a kindred with early-onset MNG and schwannomatosis was followed by investigation of germline pathogenic variants that fully segregated with the disease. Genome-wide analyses were performed on 13 tissue samples from familial and nonfamilial DGCR8-E518K–positive tumors, including MNG, schwannomas, papillary thyroid cancers (PTCs), and Wilms tumors. miRNA profiles of 4 tissue types were compared, and sequencing of miRNA, pre-miRNA, and mRNA was performed in a subset of 9 schwannomas, 4 of which harbor DGCR8-E518K.RESULTS We identified c.1552G>A;p.E518K in DGCR8, a microprocessor component located in 22q, in the kindred. The variant identified is a somatic hotspot in Wilms tumors and has been identified in 2 PTCs. Copy number loss of chromosome 22q, leading to loss of heterozygosity at the DGCR8 locus, was found in all 13 samples harboring c.1552G>A;p.E518K. miRNA profiling of PTCs, MNG, schwannomas, and Wilms tumors revealed a common profile among E518K hemizygous tumors. In vitro cleavage demonstrated improper processing of pre-miRNA by DGCR8-E518K. MicroRNA and RNA profiling show that this variant disrupts precursor microRNA production, impacting populations of canonical microRNAs and mirtrons.CONCLUSION We identified DGCR8 as the cause of an unreported autosomal dominant mendelian tumor susceptibility syndrome: familial multinodular goiter with schwannomatosis.FUNDING Canadian Institutes of Health Research, Compute Canada, Alex’s Lemonade Stand Foundation, the Mia Neri Foundation for Childhood Cancer, Cassa di Sovvenzioni e Risparmio fra il Personale della Banca d’Italia, and the KinderKrebsInitiative Buchholz/Holm-Seppensen.

Authors

Barbara Rivera, Javad Nadaf, Somayyeh Fahiminiya, Maria Apellaniz-Ruiz, Avi Saskin, Anne-Sophie Chong, Sahil Sharma, Rabea Wagener, Timothée Revil, Vincenzo Condello, Zineb Harra, Nancy Hamel, Nelly Sabbaghian, Karl Muchantef, Christian Thomas, Leanne de Kock, Marie-Noëlle Hébert-Blouin, Angelia V. Bassenden, Hannah Rabenstein, Ozgur Mete, Ralf Paschke, Marc P. Pusztaszeri, Werner Paulus, Albert Berghuis, Jiannis Ragoussis, Yuri E. Nikiforov, Reiner Siebert, Steffen Albrecht, Robert Turcotte, Martin Hasselblatt, Marc R. Fabian, William D. Foulkes

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 3 9 6 4 4 2 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
Fine Regulation of MicroRNAs in Gene Regulatory Networks and Pathophysiology
Seida M, Ogami K, Yoshino S, Suzuki HI
International Journal of Molecular Sciences 2025
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis
Perrino MR, Jongmans MC, Tomlinson GE, Greer ML, Scollon SR, Mitchell SG, Hansford JR, Schultz KA, Kohlmann WK, Kalish JM, MacFarland SP, Das A, Maxwell KN, Pfister SM, Weksberg R, Michaeli O, Tabori U, Ney GM, Lupo PJ, Brzezinski JJ, Stewart DR, Woodward ER, Kratz CP
Clinical cancer research : an official journal of the American Association for Cancer Research 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
Fiorica PN, Golmard L, Kim J, Bao R, Lin FY, Roy A, Pribnow A, Perrino MR, Masliah-Planchon J, Michalak-Provost S, Wong J, Filser M, Stoppa-Lyonnet D, Bourdeaut F, Brahimi A, Ingster O, Saulnier Sholler G, Jackson SA, Sasaki MM, Fowler T, Ng A, Corbett RJ, Kaufman RS, Haley JS, Carey DJ, Huang KL, Diskin SJ, Rokita JL, Al-Kateb H, McGee RB, Schiffman JD, Chen KS, Stewart DR, Williams Parsons D, Plon SE, Schultz KA, Onel K
Clinical Cancer Research 2025
Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma
Rodrigues L, Da Cruz Paula A, Soares P, Vinagre J
Cells 2024
Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study.
Condello V, Roberts JW, Stenman A, Larsson C, Viswanathan K, Juhlin CC
Virchows Archiv : an international journal of pathology 2024
Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors
Hansford JR, Das A, McGee RB, Nakano Y, Brzezinski J, Scollon SR, Rednam SP, Schienda J, Michaeli O, Kim SY, Greer ML, Weksberg R, Stewart DR, Foulkes WD, Tabori U, Pajtler KW, Pfister SM, Brodeur GM, Kamihara J
Clinical cancer research 2024
Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules
Condello V, Poma AM, Macerola E, Vignali P, Paulsson JO, Zedenius J, Basolo F, Juhlin CC
The Journal of clinical endocrinology and metabolism 2024
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Seyhan AA
International journal of molecular sciences 2024
Specifics of spinal neuropathology in the molecular age
Kresbach C, Hack K, Ricklefs F, Schüller U
Neuro-Oncology Advances 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Mete O, Boucher A, Schrader KA, Abdel-Rahman O, Bahig H, Ho C, Hasan OK, Lemieux B, Winquist E, Wong R, Wu J, Chau N, Ezzat S
Endocrine Pathology 2024
MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?
Condello V, Juhlin CC
European Thyroid Journal 2024
Nodule-Specific NRF2-Targeted Upregulation in Patients With KEAP1 Mutations and Familial Nontoxic Multinodular Goiter
Nishihara E, Fukata S, Hirokawa M, Higuchi M, Ito M, Nishikawa M, Miyauchi A, Matsuse M, Mitsutake N, Ito Y, Hishinuma A, Kogai T, Akamizu T
The Journal of Clinical Endocrinology and Metabolism 2024
SMARCA4-associated schwannomatosis.
Chan-Pak-Choon F, Roca C, Chong AS, Nogué C, Dahlum S, Austin R, Mar Fan H, van Spaendonck-Zwarts KY, Lambie NK, Robertson T, Siebert R, Rivera B, Foulkes WD
Acta Neuropathologica 2023
KRAS Hijacks the miRNA Regulatory Pathway in Cancer
Bortoletto AS, Parchem RJ
Cancer research 2023
Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.
Stenman A, Falhammar H, Zedenius J, Juhlin CC
Endocrine 2023
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges
Seyhan AA
International journal of molecular sciences 2023
Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis.
Terry M, Gupta R, Ravindranathan A, Wu J, Chan E, Bollen AW, Chang SM, Berger MS, Jacques L, Solomon DA
Acta Neuropathologica 2023
Genomic alterations in thyroid cancer: biological and clinical insights.
Landa I, Cabanillas ME
Nature reviews. Endocrinology 2023
The relationship between vascular endothelial growth factor expression and the risk of childhood nephroblastoma: systematic review and meta-analysis
W Liao, J Zhu, H Zhang, Y Cui, Q Peng
Translational Pediatrics 2022
Mechanisms Controlling MicroRNA Expression in Tumor
Chen S, Wang Y, Li D, Wang H, Zhao X, Yang J, Chen L, Guo M, Zhao J, Chen C, Zhou Y, Liang G, Xu L
Cells 2022
Screening of potential novel candidate genes in schwannomatosis patients
Perez\u2010Becerril C, Wallace AJ, Schlecht H, Bowers NL, Smith PT, Gokhale C, Eaton H, Charlton C, Robinson R, Charlton RS, Evans DG, Smith MJ
Human Mutation 2022
DGCR8 Microprocessor Subunit Mutation and Expression Deregulation in Thyroid Lesions
Rodrigues L, Canberk S, Macedo S, Soares P, Vinagre J
International journal of molecular sciences 2022
Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform
CA Ghossein, S Dogan, N Farhat, I Landa, B Xu
Virchows Archiv 2021
DGCR8 and the six hit, three-step model of schwannomatosis
C Nogué, AS Chong, E Grau, HR Han, E Dorca, C Roca, JL Mosquera, C Lázaro, WD Foulkes, J Brunet, B Rivera
Acta Neuropathologica 2021
TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression
JO Paulsson, J Zedenius, CC Juhlin
Endocrine Pathology 2021
Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8
JO Paulsson, N Rafati, S DiLorenzo, Y Chen, F Haglund, J Zedenius, CC Juhlin
The Journal of clinical endocrinology and metabolism 2021
Mice hypomorphic for Keap1, a negative regulator of the Nrf2 antioxidant response, show age-dependent diffuse goiter with elevated thyrotropin levels
PG Ziros, CO Renaud, DV Chartoumpekis, M Bongiovanni, I Habeos, XH Liao, S Refetoff, PA Kopp, K Brix, GP Sykiotis
Thyroid 2020
Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
FY Miasaki, CS Fuziwara, GA de Carvalho, ET Kimura
Genes & development 2020

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
55 readers on Mendeley
See more details